A randomized trial of moderately early low-dose dexamethasone therapy in very low birth weight infants: Dynamic pulmonary mechanics, oxygenation, and ventilation

Manuel Durand, Maria E. Mendoza, Phuket Tantivit, Amir Kugelman, Cynthia (Cindy) McEvoy

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Objective. Dexamethasone is used in very low birth weight (VLBW) ventilator-dependent infants to prevent or decrease the severity of chronic lung disease. We reported a significant increase in respiratory compliance during a 7-day weaning course of moderately early dexamethasone therapy (0.5 mg/kg/d) in VLBW infants, along with a shorter duration of mechanical ventilation and O2 supplementation. Although 0.5 mg/kg/d has been the most commonly used dose in preterm infants, the use of a lower dose of dexamethasone may reduce potential adverse effects of steroid therapy. Quantification of dynamic pulmonary mechanics in VLBW infants who receive low-dose dexamethasone has not been reported. The objective of this study was to compare the effect of 2 dose regimens of dexamethasone on dynamic pulmonary mechanics, mean airway pressure (MAP), and fractional inspired oxygen concentration (FIO2) in intubated VLBW infants who were at risk for chronic lung disease. Methods. We studied 47 VLBW (birth weight: 550-1290 g; gestational age: 24-30 weeks) ventilator-dependent infants at 7 to 14 days of age. Twenty-three infants were randomized to receive dexamethasone at 0.5 mg/kg/d intravenously for 3 days (high dose), 0.25 mg/kg/d for 3 days, and 0.1 mg/kg/d during the 7th day; 24 infants received low-dose dexamethasone as 0.2 mg/kg/d for 3 days and 0.1 mg/kg/d for 4 days. Respiratory compliance (Crs) and resistance were measured before and on days 2, 5, and 7 of dexamethasone therapy. We recorded airway pressure, flow, and tidal volume, and mechanical breaths were analyzed. Results. Crs significantly increased during dexamethasone therapy in both groups of infants when compared with baseline (74% increase in the high-dose group and 66% increase in the low-dose group). Dexamethasone increased tidal volume and significantly reduced FIO2 and MAP in both groups of infants. A transient increase in blood pressure was noted in both groups. Conclusions. Our findings indicate that 1) comparable significant increases in Crs are present in the low-dose dexamethasone as well as the high-dose dexamethasone groups on days 2, 5, and 7 of steroid therapy; and 2) MAP and FIO2 are significantly decreased during dexamethasone therapy in both groups of infants. We conclude that low-dose and high-dose dexamethasone, as used in this study, have comparable beneficial effects on dynamic pulmonary mechanics and subsequently on oxygen requirement and applied ventilatory support in VLBW infants.

Original languageEnglish (US)
Pages (from-to)262-268
Number of pages7
JournalPediatrics
Volume109
Issue number2 I
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Very Low Birth Weight Infant
Mechanics
Dexamethasone
Ventilation
Lung
Therapeutics
Pressure
Tidal Volume
Mechanical Ventilators
Lung Diseases
Compliance
Chronic Disease
Steroids
Oxygen
Secondary Prevention
Weaning
Artificial Respiration
Birth Weight
Premature Infants
Gestational Age

Keywords

  • Dynamic respiratory compliance
  • Low-dose dexamethasone
  • Mean airway pressure
  • Oxygenation
  • Very low birth weight infants

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

A randomized trial of moderately early low-dose dexamethasone therapy in very low birth weight infants : Dynamic pulmonary mechanics, oxygenation, and ventilation. / Durand, Manuel; Mendoza, Maria E.; Tantivit, Phuket; Kugelman, Amir; McEvoy, Cynthia (Cindy).

In: Pediatrics, Vol. 109, No. 2 I, 2002, p. 262-268.

Research output: Contribution to journalArticle

@article{c49bddbfe8db46a0919d215fc5df80af,
title = "A randomized trial of moderately early low-dose dexamethasone therapy in very low birth weight infants: Dynamic pulmonary mechanics, oxygenation, and ventilation",
abstract = "Objective. Dexamethasone is used in very low birth weight (VLBW) ventilator-dependent infants to prevent or decrease the severity of chronic lung disease. We reported a significant increase in respiratory compliance during a 7-day weaning course of moderately early dexamethasone therapy (0.5 mg/kg/d) in VLBW infants, along with a shorter duration of mechanical ventilation and O2 supplementation. Although 0.5 mg/kg/d has been the most commonly used dose in preterm infants, the use of a lower dose of dexamethasone may reduce potential adverse effects of steroid therapy. Quantification of dynamic pulmonary mechanics in VLBW infants who receive low-dose dexamethasone has not been reported. The objective of this study was to compare the effect of 2 dose regimens of dexamethasone on dynamic pulmonary mechanics, mean airway pressure (MAP), and fractional inspired oxygen concentration (FIO2) in intubated VLBW infants who were at risk for chronic lung disease. Methods. We studied 47 VLBW (birth weight: 550-1290 g; gestational age: 24-30 weeks) ventilator-dependent infants at 7 to 14 days of age. Twenty-three infants were randomized to receive dexamethasone at 0.5 mg/kg/d intravenously for 3 days (high dose), 0.25 mg/kg/d for 3 days, and 0.1 mg/kg/d during the 7th day; 24 infants received low-dose dexamethasone as 0.2 mg/kg/d for 3 days and 0.1 mg/kg/d for 4 days. Respiratory compliance (Crs) and resistance were measured before and on days 2, 5, and 7 of dexamethasone therapy. We recorded airway pressure, flow, and tidal volume, and mechanical breaths were analyzed. Results. Crs significantly increased during dexamethasone therapy in both groups of infants when compared with baseline (74{\%} increase in the high-dose group and 66{\%} increase in the low-dose group). Dexamethasone increased tidal volume and significantly reduced FIO2 and MAP in both groups of infants. A transient increase in blood pressure was noted in both groups. Conclusions. Our findings indicate that 1) comparable significant increases in Crs are present in the low-dose dexamethasone as well as the high-dose dexamethasone groups on days 2, 5, and 7 of steroid therapy; and 2) MAP and FIO2 are significantly decreased during dexamethasone therapy in both groups of infants. We conclude that low-dose and high-dose dexamethasone, as used in this study, have comparable beneficial effects on dynamic pulmonary mechanics and subsequently on oxygen requirement and applied ventilatory support in VLBW infants.",
keywords = "Dynamic respiratory compliance, Low-dose dexamethasone, Mean airway pressure, Oxygenation, Very low birth weight infants",
author = "Manuel Durand and Mendoza, {Maria E.} and Phuket Tantivit and Amir Kugelman and McEvoy, {Cynthia (Cindy)}",
year = "2002",
doi = "10.1542/peds.109.2.262",
language = "English (US)",
volume = "109",
pages = "262--268",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "2 I",

}

TY - JOUR

T1 - A randomized trial of moderately early low-dose dexamethasone therapy in very low birth weight infants

T2 - Dynamic pulmonary mechanics, oxygenation, and ventilation

AU - Durand, Manuel

AU - Mendoza, Maria E.

AU - Tantivit, Phuket

AU - Kugelman, Amir

AU - McEvoy, Cynthia (Cindy)

PY - 2002

Y1 - 2002

N2 - Objective. Dexamethasone is used in very low birth weight (VLBW) ventilator-dependent infants to prevent or decrease the severity of chronic lung disease. We reported a significant increase in respiratory compliance during a 7-day weaning course of moderately early dexamethasone therapy (0.5 mg/kg/d) in VLBW infants, along with a shorter duration of mechanical ventilation and O2 supplementation. Although 0.5 mg/kg/d has been the most commonly used dose in preterm infants, the use of a lower dose of dexamethasone may reduce potential adverse effects of steroid therapy. Quantification of dynamic pulmonary mechanics in VLBW infants who receive low-dose dexamethasone has not been reported. The objective of this study was to compare the effect of 2 dose regimens of dexamethasone on dynamic pulmonary mechanics, mean airway pressure (MAP), and fractional inspired oxygen concentration (FIO2) in intubated VLBW infants who were at risk for chronic lung disease. Methods. We studied 47 VLBW (birth weight: 550-1290 g; gestational age: 24-30 weeks) ventilator-dependent infants at 7 to 14 days of age. Twenty-three infants were randomized to receive dexamethasone at 0.5 mg/kg/d intravenously for 3 days (high dose), 0.25 mg/kg/d for 3 days, and 0.1 mg/kg/d during the 7th day; 24 infants received low-dose dexamethasone as 0.2 mg/kg/d for 3 days and 0.1 mg/kg/d for 4 days. Respiratory compliance (Crs) and resistance were measured before and on days 2, 5, and 7 of dexamethasone therapy. We recorded airway pressure, flow, and tidal volume, and mechanical breaths were analyzed. Results. Crs significantly increased during dexamethasone therapy in both groups of infants when compared with baseline (74% increase in the high-dose group and 66% increase in the low-dose group). Dexamethasone increased tidal volume and significantly reduced FIO2 and MAP in both groups of infants. A transient increase in blood pressure was noted in both groups. Conclusions. Our findings indicate that 1) comparable significant increases in Crs are present in the low-dose dexamethasone as well as the high-dose dexamethasone groups on days 2, 5, and 7 of steroid therapy; and 2) MAP and FIO2 are significantly decreased during dexamethasone therapy in both groups of infants. We conclude that low-dose and high-dose dexamethasone, as used in this study, have comparable beneficial effects on dynamic pulmonary mechanics and subsequently on oxygen requirement and applied ventilatory support in VLBW infants.

AB - Objective. Dexamethasone is used in very low birth weight (VLBW) ventilator-dependent infants to prevent or decrease the severity of chronic lung disease. We reported a significant increase in respiratory compliance during a 7-day weaning course of moderately early dexamethasone therapy (0.5 mg/kg/d) in VLBW infants, along with a shorter duration of mechanical ventilation and O2 supplementation. Although 0.5 mg/kg/d has been the most commonly used dose in preterm infants, the use of a lower dose of dexamethasone may reduce potential adverse effects of steroid therapy. Quantification of dynamic pulmonary mechanics in VLBW infants who receive low-dose dexamethasone has not been reported. The objective of this study was to compare the effect of 2 dose regimens of dexamethasone on dynamic pulmonary mechanics, mean airway pressure (MAP), and fractional inspired oxygen concentration (FIO2) in intubated VLBW infants who were at risk for chronic lung disease. Methods. We studied 47 VLBW (birth weight: 550-1290 g; gestational age: 24-30 weeks) ventilator-dependent infants at 7 to 14 days of age. Twenty-three infants were randomized to receive dexamethasone at 0.5 mg/kg/d intravenously for 3 days (high dose), 0.25 mg/kg/d for 3 days, and 0.1 mg/kg/d during the 7th day; 24 infants received low-dose dexamethasone as 0.2 mg/kg/d for 3 days and 0.1 mg/kg/d for 4 days. Respiratory compliance (Crs) and resistance were measured before and on days 2, 5, and 7 of dexamethasone therapy. We recorded airway pressure, flow, and tidal volume, and mechanical breaths were analyzed. Results. Crs significantly increased during dexamethasone therapy in both groups of infants when compared with baseline (74% increase in the high-dose group and 66% increase in the low-dose group). Dexamethasone increased tidal volume and significantly reduced FIO2 and MAP in both groups of infants. A transient increase in blood pressure was noted in both groups. Conclusions. Our findings indicate that 1) comparable significant increases in Crs are present in the low-dose dexamethasone as well as the high-dose dexamethasone groups on days 2, 5, and 7 of steroid therapy; and 2) MAP and FIO2 are significantly decreased during dexamethasone therapy in both groups of infants. We conclude that low-dose and high-dose dexamethasone, as used in this study, have comparable beneficial effects on dynamic pulmonary mechanics and subsequently on oxygen requirement and applied ventilatory support in VLBW infants.

KW - Dynamic respiratory compliance

KW - Low-dose dexamethasone

KW - Mean airway pressure

KW - Oxygenation

KW - Very low birth weight infants

UR - http://www.scopus.com/inward/record.url?scp=0036159199&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036159199&partnerID=8YFLogxK

U2 - 10.1542/peds.109.2.262

DO - 10.1542/peds.109.2.262

M3 - Article

C2 - 11826205

AN - SCOPUS:0036159199

VL - 109

SP - 262

EP - 268

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 2 I

ER -